Agios Pharmaceuticals Inc  (AGIO) - NASDAQGS

  Revenue / EPS Summary *  
 
 Fiscal Quarter 2019
(Fiscal Year)
2018
(Fiscal Year)
2017
(Fiscal Year)
March      
   Revenue $30,227(t) $8,762(t) $10,508(t)
   EPS -1.59 (3/31/2019) -1.63 (3/31/2018) -1.56 (3/31/2017)
   Dividends N/A N/A N/A
June      
   Revenue $26,221(t) $40,414(t) $11,346(t)
   EPS -1.87 (6/30/2019) -1.18 (6/30/2018) -1.79 (6/30/2017)
   Dividends N/A N/A N/A
September      
   Revenue $26,024(t) $15,198(t) $11,358(t)
   EPS -1.81 (9/30/2019) -1.64 (9/30/2018) -1.59 (9/30/2017)
   Dividends N/A N/A N/A
December  (FYE)      
   Revenue   $30,013(t) $9,799(t)
   EPS   -1.58 (12/31/2018) -1.81 (12/31/2017)
   Dividends   N/A N/A
Totals      
   Revenue $82,472(t) $94,387(t) $43,011(t)
   EPS -5.27 -6.03 -6.75
   Dividends N/A N/A N/A
   Previous 3 Years
 
 
©2019, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.